Progression of double-hit lymphoma in the midst of R-hyper CVAD

American Journal of Hematology

Volumn 88, Issue 1, 2013, Pages 87-88

  Munoz, Javier ^a   Vekaria, Mona ^a   Hanbali, Amr ^a   Janakiraman, Nalini ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CISPLATIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PROTEIN BCL 2; RITUXIMAB; VINCRISTINE;

ADULT; ANTIBIOTIC THERAPY; APOPTOSIS; BONE MARROW BIOPSY; BONE MARROW INFILTRATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CASE REPORT; DOUBLE HIT LYMPHOMA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LARGE CELL LYMPHOMA; LUNG EMBOLISM; LYMPHADENOPATHY; LYMPHOMA; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; NOTE; PLEURA EFFUSION; PRIORITY JOURNAL; THROMBOCYTOPENIA; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, FOLLICULAR; MEDIASTINAL NEOPLASMS; MIDDLE AGED; VINCRISTINE;

EID: 84871455935     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23206     Document Type: Note

References (14)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
2. Aukema SM, Siebert R, Schuuring E, et al. Double-hit B-cell lymphomas. Blood 2011 24;117: 2319-2331.
3. Lin P, Medeiros JL. High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis. Hematologica 2007; 92: 1297-1301.
4. Boerma EG, Siebert R, Klui PM, Baudis M. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge. Leukemia 2009; 23: 225-234.
5. Johnson NA, Savage KJ. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 2009; 114: 2273-2279.
6. Motlló C, Grau J, Juncà J, et al. Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. Cancer Genet Cytogenet 2010; 203: 328-332.
7. Montoto S, Davies AJ, Matthews J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007; 25: 2426-2433.
8. Hill BT, Sweetenham J. Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma. Leuk Lymph. 2012 Jan 5. Epub ahead of print.
9. Choi WW, Weisenburger DD, Greiner TC, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 2009; 15: 5494-5502.
10. Lenz G, Wright GW, Emre NC, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008; 105: 13520-13525.
11. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354: 2419-2430.
12. Carbone A, Gloghini A, Aiello A, et al. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol 2010; 41: 621-631.
13. Tomita N. BCL2 and MYC dual-hit lymphoma/leukemia. J Clin Exp Hematol 2011; 51: 7-12.
14. Tomita N, Tokunaka M, Nakamura N, et al. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica 2009; 94: 935-943.